
Roivant Sciences Ltd. – NASDAQ:ROIVW
Roivant Sciences Ltd. stock price monthly change
Roivant Sciences Ltd. stock price quarterly change
Roivant Sciences Ltd. stock price yearly change
Roivant Sciences Ltd. key metrics
Market Cap | 8.32B |
Enterprise value | N/A |
P/E | -0.34 |
EV/Sales | -1.47 |
EV/EBITDA | 0.05 |
Price/Sales | 22.82 |
Price/Book | 1.03 |
PEG ratio | 0.07 |
EPS | -1.26 |
Revenue | 89.87M |
EBITDA | -817.36M |
Income | -902.38M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -2887.92% |
Oper. margin | -2800.93% |
Gross margin | 78.18% |
EBIT margin | -2800.93% |
EBITDA margin | -909.5% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRoivant Sciences Ltd. stock price history
Roivant Sciences Ltd. stock forecast
Roivant Sciences Ltd. financial statements
Dec 2021 | 24.34M | -284.53M | -1168.96% |
---|---|---|---|
Mar 2022 | 9.22M | -291.31M | -3158.55% |
Mar 2023 | 27.37M | -175.42M | -640.79% |
Mar 2024 | 28.93M | -151.11M | -522.35% |
Sep 2022 | 2215534000 | 701.38M | 31.66% |
---|---|---|---|
Dec 2022 | 2202960000 | 775.82M | 35.22% |
Mar 2023 | 2389604000 | 782.01M | 32.73% |
Mar 2024 | 7222482000 | 773.95M | 10.72% |
Dec 2021 | -268.49M | -6.07M | -8.42M |
---|---|---|---|
Mar 2022 | -147.46M | -5.70M | 1.07M |
Mar 2023 | -179.08M | 113.55M | 210.33M |
Mar 2024 | -108.45M | 6.92M | -32.62M |
Roivant Sciences Ltd. alternative data
Aug 2023 | 620 |
---|---|
Sep 2023 | 620 |
Oct 2023 | 620 |
Nov 2023 | 620 |
Dec 2023 | 620 |
Jan 2024 | 620 |
Feb 2024 | 620 |
Mar 2024 | 620 |
Apr 2024 | 620 |
May 2024 | 620 |
Jun 2024 | 620 |
Jul 2024 | 620 |
Roivant Sciences Ltd. other data
Period | Buy | Sel |
---|---|---|
Mar 2022 | 0 | 357794 |
Apr 2022 | 40285 | 14319 |
May 2022 | 0 | 288339 |
Jun 2022 | 0 | 37892 |
Jul 2022 | 0 | 39037 |
Aug 2022 | 0 | 38191 |
Sep 2022 | 0 | 40186 |
Oct 2022 | 0 | 36786 |
Nov 2022 | 4000000 | 19578585 |
Dec 2022 | 0 | 168866 |
Jan 2023 | 0 | 119521 |
Feb 2023 | 0 | 4000000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | RAMASWAMY VIVEK director | Common Shares | 4,000,000 | $7.95 | $31,800,000 | ||
Sale | VENKER ERIC officer: President & COO | Common Shares | 24,037 | $8.02 | $192,777 | ||
Sale | VENKER ERIC officer: President & COO | Common Shares | 95,484 | $7.32 | $698,943 | ||
Sale | VENKER ERIC officer: President & COO | Common Shares | 23,761 | $8 | $190,088 | ||
Sale | VENKER ERIC officer: President & COO | Common Shares | 133,376 | $7.03 | $937,633 | ||
Sale | VENKER ERIC officer: President & COO | Common Shares | 11,729 | $7 | $82,103 | ||
Purchase | DEXCEL PHARMA TECHNOLOGIES LTD. 10 percent owner | Common Shares | 4,000,000 | $5 | $20,000,000 | ||
Sale | GOLD DANIEL ALLEN director | Common Shares | 1,733,577 | $4.75 | $8,234,491 | ||
Sale | GOLD DANIEL ALLEN director | Common Shares | 1,092,355 | $4.75 | $5,188,686 | ||
Sale | QVT FINANCIAL LP other | Common Shares | 146,079 | $4.75 | $693,875 |
-
When is Roivant Sciences Ltd.'s next earnings date?
Unfortunately, Roivant Sciences Ltd.'s (ROIVW) next earnings date is currently unknown.
-
Does Roivant Sciences Ltd. pay dividends?
No, Roivant Sciences Ltd. does not pay dividends.
-
How much money does Roivant Sciences Ltd. make?
Roivant Sciences Ltd. has a market capitalization of 8.32B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 125.73% to 124.8M US dollars.
-
What is Roivant Sciences Ltd.'s stock symbol?
Roivant Sciences Ltd. is traded on the NASDAQ under the ticker symbol "ROIVW".
-
What is Roivant Sciences Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Roivant Sciences Ltd.?
Shares of Roivant Sciences Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Roivant Sciences Ltd. have?
As Jul 2024, Roivant Sciences Ltd. employs 620 workers.
-
When Roivant Sciences Ltd. went public?
Roivant Sciences Ltd. is publicly traded company for more then 3 years since IPO on 27 Sep 2021.
-
What is Roivant Sciences Ltd.'s official website?
The official website for Roivant Sciences Ltd. is roivant.com.
-
How can i contact Roivant Sciences Ltd.?
Roivant Sciences Ltd. can be reached via phone at +44 4412955950.
Roivant Sciences Ltd. company profile:

Roivant Sciences Ltd.
roivant.comNASDAQ
620
Biotechnology
Healthcare
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
London, SW1Y 4LB
CIK: 0001635088
:
CUSIP: G76279119